We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$6.59B
AUM Growth
-$836M
Cap. Flow
-$1.17B
Cap. Flow %
-17.84%
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$18.4M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$15.6M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$15.4M
4
META icon
Meta Platforms (Facebook)
META
+$15M
5
ADBE icon
Adobe
ADBE
+$13.1M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$23.1M
2
PANW icon
Palo Alto Networks
PANW
+$20.9M
3
CI icon
Cigna
CI
+$16.5M
4
CHTR icon
Charter Communications
CHTR
+$15.8M
5
CYTK icon
Cytokinetics
CYTK
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 2.73%
2 Communication Services 2.58%
3 Financials 2.16%
4 Technology 1.6%
5 Consumer Discretionary 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
376
Annexon
ANNX
$880M
$3.58M 0.05%
+500,000
New +$2.6M
OGN icon
377
PUT
Organon & Co
OGN
$3.56B
$3.57M 0.05%
190,000
+40,000
+27% +$686K
ELAN icon
378
Elanco Animal Health
ELAN
$12.7B
$3.57M 0.05%
219,054
-20,946
-9% -$327K
PCRX icon
379
PUT
Pacira BioSciences
PCRX
$1.08B
$3.56M 0.05%
+122,000
New +$3.75M
IREN icon
380
CALL
Iris Energy
IREN
$14.6B
$3.56M 0.05%
660,000
+83,100
+14% +$451K
APLS
381
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$3.53M 0.05%
60,000
-276,400
-82% -$17.6M
APLS
382
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$3.53M 0.05%
60,000
-179,300
-75% -$11.4M
SMG icon
383
CALL
ScottsMiracle-Gro
SMG
$3.87B
$3.51M 0.05%
+47,100
New +$2.93M
ELAN icon
384
CALL
Elanco Animal Health
ELAN
$12.7B
$3.51M 0.05%
215,700
+65,000
+43% +$1.02M
PCRX icon
385
CALL
Pacira BioSciences
PCRX
$1.08B
$3.5M 0.05%
+119,900
New +$3.68M
GRPN icon
386
PUT
Groupon
GRPN
$1.05B
$3.48M 0.05%
260,900
-73,300
-22% -$1.12M
OSCR icon
387
PUT
Oscar Health
OSCR
$9.23B
$3.46M 0.05%
233,000
-16,000
-6% -$219K
THRM icon
388
CALL
Gentherm
THRM
$1.32B
$3.45M 0.05%
60,000
– –
NBIX icon
389
PUT
Neurocrine Biosciences
NBIX
$16.9B
$3.45M 0.05%
25,000
-29,900
-54% -$4.08M
ASTL icon
390
CALL
Algoma Steel
ASTL
$443M
$3.44M 0.05%
405,600
-4,600
-1% -$38.9K
CHEF icon
391
CALL
Chefs' Warehouse
CHEF
$4.48B
$3.43M 0.05%
+91,100
New +$3.12M
CHRW icon
392
CALL
C.H. Robinson
CHRW
$18.1B
$3.43M 0.05%
+45,000
New +$3.52M
CHRW icon
393
PUT
C.H. Robinson
CHRW
$18.1B
$3.43M 0.05%
+45,000
New +$3.52M
MRNS
394
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.42M 0.05%
+378,400
New +$3.68M
RTX icon
395
RTX Corp
RTX
$293B
$3.41M 0.05%
35,000
+32,000
+1,067% +$2.89M
DVN icon
396
Devon Energy
DVN
$50.6B
$3.4M 0.05%
+67,700
New +$3.01M
ACAD icon
397
PUT
Acadia Pharmaceuticals
ACAD
$4.61B
$3.39M 0.05%
+183,400
New +$4.54M
PRKS icon
398
CALL
United Parks & Resorts
PRKS
$2.18B
$3.37M 0.05%
60,000
+15,000
+33% +$761K
PRKS icon
399
PUT
United Parks & Resorts
PRKS
$2.18B
$3.37M 0.05%
+60,000
New +$3.04M
CLDX icon
400
CALL
Celldex Therapeutics
CLDX
$3.07B
$3.36M 0.05%
80,000
-35,000
-30% -$1.44M
14 15
16
17 18

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q1 2024 Portfolio in Review

As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management withdrew a net $1.17B in Q1 2024, closing 676 positions and reducing 294 holdings. Its most notable exit was Palo Alto Networks, an estimated $20.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.7% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Caption Management opened a new position in Adobe worth $11.5M.

  • Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
  • Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
  • Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
  • Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
  • Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
  • Caption Management opened 509 new positions and closed 676 in Q1 2024.
  • Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.